Secretor Status and Its Forensic Value

About 80% of people secrete ABO blood-group antigens into body fluids such as saliva and semen, a trait controlled by the FUT2 gene. Secretor status multiplied the discriminating power of pre-DNA forensic serology and remains relevant alongside modern DNA methods.

Last updated: 10 Jun 2026

Imagine two people with group B blood. One leaves a bite mark with saliva on a victim's skin; the other does not. The serologist swabs both sites and runs an inhibition test. From the first swab, anti-B antiserum is strongly neutralised, pointing directly at a group B donor. From the second, nothing happens: the antiserum retains full activity, as though no body fluid was present at all. The difference is not the ABO group of the two attackers, which is identical. The difference is their secretor status, a trait governed by a single gene locus that determines whether ABO antigens appear in saliva, semen, and other body secretions.

The FUT2 gene, on chromosome 19, encodes a fucosyltransferase that adds fucose to precursor oligosaccharide chains on mucin glycoproteins in secretory epithelium. The result is soluble H antigen in body fluids, which is then further modified, in secretors who carry A or B alleles, into soluble A or B antigen. About 80% of most tested populations carry at least one functional FUT2 allele and are secretors. The remaining 20% are homozygous for non-functional alleles and produce no blood-group substance in their secretions, even though their red cells display perfectly normal ABO antigens.

For pre-DNA forensic serology, secretor typing was not just a supplementary test. It was the gateway to ABO typing from body fluids other than blood. Rape cases, assault with bite marks, cases involving saliva on cigarette butts or envelopes: all of these depended on secretor status to generate any useful typing information at all. Combined with ABO blood group, secretor status multiplied the discriminating power available to analysts. This topic covers the genetics, the population biology, and the forensic mechanics of the secretor system.

Key terms

Secretor: An individual who expresses ABO blood-group antigens in soluble form in body fluids, due to carrying at least one functional FUT2 allele encoding a secretory fucosyltransferase.
Non-secretor: An individual homozygous for non-functional FUT2 alleles who produces no H, A, or B antigen in saliva, semen, or other exocrine secretions, despite having normal ABO antigens on red cells.
FUT2 gene: The Fucosyltransferase 2 gene on chromosome 19q13, encoding the alpha-1,2-fucosyltransferase enzyme responsible for adding fucose to type-1 chain precursors in secretory tissues to generate H substance in body fluids.
Blood-group substance: Soluble ABO antigens (A substance, B substance, H substance) present in the body fluids of secretors. Chemically distinct from the glycolipid-bound cell-surface antigens but carrying the same specificities.
Se gene / Se428: The original notation for the secretor locus (Se for secretor, se or FUT2*428A for the non-secretor null allele carrying a nonsense mutation at codon 428). The most common non-secretor allele in European and Asian populations.
Inhibition index: The titre drop in anti-A, anti-B, or anti-H antiserum after incubation with a body-fluid extract. A drop of two or more serial dilutions is conventionally taken as evidence of the corresponding blood-group substance.

The genetics of secretor status

Two alleles at one locus determine whether your body fluids will ever give up your ABO group.

The secretor locus is distinct from the ABO locus. They are on different chromosomes: ABO on chromosome 9, FUT2 on chromosome 19. The ABO genotype determines what antigens are built on red cells and, in secretors, in body fluids. The FUT2 genotype determines whether body-fluid antigen synthesis happens at all.

The FUT2 enzyme works on type-1 chain precursors found in secretory epithelium (gut, salivary glands, reproductive tract). It adds a fucose residue to generate type-1 H antigen. Once H is in place, the ABO transferase enzymes can add A- or B-specific sugars, exactly as they do on red cells. Without the FUT2 enzyme, no H is built in secretory tissues, and therefore no A or B antigen is produced in body fluids regardless of the ABO genotype.

The most common non-secretor allele in European and East Asian populations is a nonsense mutation at codon 428 of FUT2, which introduces a premature stop codon and abolishes enzyme activity. Homozygotes for this allele (se/se or Se428/Se428 in modern notation) are non-secretors. A heterozygote (Se/se) is a secretor: one functional copy of FUT2 is sufficient for normal secretion. Additional non-secretor alleles exist at lower frequencies in African and other populations.

FUT2 genotype determines secretor phenotype: one functional allele is sufficient.

Population frequencies and ethnic variation

The secretor frequency of about 80% holds broadly across many populations, but the non-secretor alleles differ.

Population surveys of secretor status have been conducted since the 1930s. The classic result is that approximately 80% of European, East Asian, and South Asian populations are secretors and approximately 20% are non-secretors. This proportion is remarkably consistent, though the underlying allele frequencies differ. In West African populations, alternative non-secretor alleles and partial-secretor alleles are more common, and the secretor frequency varies more widely between ethnic groups.

Population	Approx. secretor %	Approx. non-secretor %
Northern European	78-80%	20-22%
South Asian	75-80%	20-25%
East Asian	76-80%	20-24%
West African	65-75%	25-35%
Amerindian (varies by group)	96-100%	0-4%

The near-complete secretor status in some Amerindian groups is a textbook example of founder effect and population bottleneck. For forensic purposes, these frequency differences matter: if the reference population for a case has a non-secretor frequency different from the European 20%, using the wrong database overstates or understates the significance of a non-secretor result.

ABO antigens in body fluids: where and how much

Saliva is the richest source; semen and urine are useful; sweat and tears are too dilute for practical typing.

In secretors, blood-group substances appear in all exocrine secretions, but in very different concentrations. Saliva is by far the most concentrated source, with A, B, or H substance detectable at microgram-per-millilitre concentrations in whole saliva from a secretor. This makes saliva stains on cigarette butts, postage stamp adhesive (licked), and bite-mark swabs strong candidates for secretor typing.

Saliva: highest concentration of blood-group substance; reliable typing from small volumes; primary substrate for bite-mark and discarded-item analysis.
Semen: secretors have H, A, or B substance in the seminal plasma; concentrations lower than saliva but sufficient for inhibition typing from a single ejaculate stain; the main substrate in pre-DNA rape-case serology.
Vaginal secretions: present in secretors; useful for corroborating donor typing in mixed stains where male-fraction DNA may be absent.
Urine: secretors excrete blood-group substance in urine; useful for typed urinary stains at scenes but less concentrated than saliva.
Sweat and tears: contain trace blood-group substance in secretors; generally too dilute for reliable forensic typing from dried residues.

Non-secretors produce essentially none of these soluble antigens. Their sweat, saliva, and semen carry only background-level non-specific inhibition when tested. An analyst encountering no inhibition from a saliva stain cannot conclude the donor is group O; they must consider whether the donor is a non-secretor of any ABO group. This is why determining whether a stain is from a secretor or non-secretor was a prior step before ABO typing from body fluids.

Forensic typing protocol: inhibition on body-fluid stains

The test itself is simple in principle; the interpretation is where experience is required.

The inhibition test for secretor typing is a variant of the absorption-inhibition method. The stain extract is mixed with defined volumes of anti-H lectin (from Ulex europaeus, specific for H antigen), anti-A, and anti-B antisera. Each mixture is incubated, then indicator cells are added: O cells for the anti-H test, A cells for anti-A, B cells for anti-B. A titre drop compared to the control confirms the presence of the corresponding substance.

1. Secretor screen
The anti-H lectin test is run first. A significant titre drop indicates the stain contains H substance, confirming the donor is a secretor. No drop indicates a non-secretor; ABO typing from this stain will not be informative.
2. ABO group typing
If the secretor screen is positive, anti-A and anti-B inhibition tests are run in parallel. Titre drops identify which specific antigen is present. The combination of inhibition results gives the ABO group of the secretor donor.
3. Cross-checking with blood typing
Where a bloodstain is also available from the same scene, the ABO type from the blood should agree with the type from the body-fluid stain (if from the same person). Discrepancies flag either mixed stains or typing errors, both requiring investigation before reporting.

Secretor typing workflow: screen with anti-H, then type with anti-A and anti-B if secretor confirmed.

How secretor status multiplied discriminating power in pre-DNA casework

Combining ABO group with secretor status roughly doubled the forensic information from a body-fluid stain.

The multiplication of discriminating power works through simple probability. If group B occurs in 9% of a reference population and secretors are 80% of the population, then group B secretors are approximately 9% times 80%, or about 7.2% of the population. Non-secretors who are group B are 9% times 20%, or 1.8%. Telling a group B secretor stain from a group B non-secretor stain doubles the resolution within the group B fraction.

In practice, the UK Home Office Forensic Science Service and equivalent laboratories in other countries built multi-system profiles through the 1970s and 1980s, combining ABO with secretor status, Rh blood group, and red-cell enzyme polymorphisms (such as phosphoglucomutase and esterase D isoforms). These profiles could reduce the matching fraction of the reference population to a few percent, sometimes lower. The Colin Pitchfork case in 1986, which ended with the first DNA-based conviction in the UK, was preceded by conventional serology that had already identified that the Narborough murderer was a group A secretor, a category matching about 33% of the local male population.

Secretor status in the DNA era

The technique is largely retired from primary casework, but it has not disappeared.

STR DNA profiling renders secretor typing redundant for most modern casework. A full STR profile from a semen stain or a saliva stain is more discriminating by orders of magnitude than any combination of serological typing results. The FUT2 genotype itself can be determined from DNA, so if secretor status information is ever needed, it is technically possible to derive it from the same extract used for STR typing.

Where secretor biology retains forensic relevance is in two areas. First, historical case review: a large number of convictions in several jurisdictions rest partly on pre-DNA serological evidence including secretor typing. Analysts reviewing these cases need to understand what was tested, how it was interpreted, and whether the interpretation was correct. Second, degraded evidence: in samples so degraded that STR profiling fails, the carbohydrate-based ABO and secretor antigens sometimes survive and can still yield class-level information.

Historical case review: convictions based on serological secretor evidence require analysts fluent in the methodology and the failure modes to assess whether the original interpretation was justified.
Triage screening: a rapid secretor screen on a scene exhibit can confirm the presence of a human secretory body fluid before DNA resources are committed.
Research and educational contexts: FUT2 allele frequency studies continue in population genetics and infectious disease epidemiology, generating data that inform forensic reference databases.

Worked example

A bite-mark swab in a sexual assault investigation: secretor typing in practice

One swab, one inhibition test, and a clear exclusion based on secretor status.

A sexual assault victim presents with a bite mark on the left shoulder. The examining clinician swabs the bite area and preserves the swab. The victim is a known group AB secretor. A suspect is identified; his blood is taken and he types as group O, and a buccal swab confirms he is a secretor. The question is whether any of the saliva in the bite mark can be typed and whether it is consistent with or excludes the suspect.

Anti-H inhibition screen. The bite-swab extract is mixed with anti-H Ulex lectin. Significant titre drop is observed, confirming the presence of H substance. The bite-mark donor is a secretor.
ABO typing by inhibition. Anti-A and anti-B are tested in parallel with the swab extract. Anti-A shows no titre drop. Anti-B shows no titre drop. Neither A nor B substance is detected. The substance present is H only, consistent with a group O secretor donor.
Interpretation. The bite-mark saliva is consistent with originating from a group O secretor. The suspect is group O and a secretor. He cannot be excluded on secretor typing. In the local population, approximately 44% of individuals are group O; of those, about 80% are secretors, giving an O-secretor population frequency of approximately 35%. Roughly one in three men in the reference population could also produce this typing result.
Caveats. The victim is group AB; her saliva on her own skin carries both A and B substance. If her secretions contaminate the bite swab, we would expect A and B inhibition. None is observed, suggesting the swab picked up primarily the attacker's saliva rather than the victim's. This is a useful internal consistency check, not a guarantee.

In a modern investigation, this swab would proceed directly to DNA extraction and STR profiling, which would generate a far more discriminating result. But the worked example shows how a pre-DNA analyst extracted meaningful information from a saliva stain, correctly framed it as a population fraction, and used the victim's known type as an internal cross-check. The reasoning is sound; the discriminating power is just much lower than DNA.

Check your understanding

Question 1 of 4· 0 answered

A saliva stain on a postage stamp shows no inhibition with anti-H, anti-A, or anti-B. What is the most likely explanation?

Key Takeaways

Secretor status, controlled by the FUT2 gene on chromosome 19, determines whether ABO blood-group antigens appear in soluble form in saliva, semen, and other body fluids; approximately 80% of most populations are secretors.
Non-secretors carry two non-functional FUT2 alleles and produce no H, A, or B substance in secretions; their body-fluid stains cannot be ABO typed serologically regardless of their red-cell group.
The inhibition method, using anti-H lectin, anti-A, and anti-B antisera, was the standard forensic technique for typing saliva and semen stains; significant titre drop confirms the presence of the corresponding blood-group substance.
Combining ABO group and secretor status roughly doubled the discriminating power compared to ABO alone; the 1986 Narborough investigation demonstrated operational-scale secretor screening before DNA profiling superseded these methods.
Secretor typing has largely been displaced by STR DNA profiling but remains important for understanding historical case reports and for interpreting degraded samples where DNA extraction fails.

What does it mean to be a secretor?

A secretor is a person who expresses ABO blood-group antigens (A, B, and/or H antigen) in soluble form in body fluids such as saliva, semen, vaginal secretions, tears, and urine. Whether someone is a secretor depends on the FUT2 gene, which encodes the enzyme needed to attach H antigen to mucin-type glycoproteins in secretions. About 80% of most populations are secretors.

Which gene controls secretor status, and how?

The FUT2 gene on chromosome 19 encodes a secretory fucosyltransferase enzyme that adds fucose to precursor chains in secretory gland epithelium, creating H antigen in soluble form. People who carry at least one functional FUT2 allele are secretors. Non-secretors carry two non-functional alleles and produce no H, A, or B substance in secretions, even though their red cells carry the normal ABO antigens.

How was secretor testing performed on crime-scene samples?

The absorption-inhibition test was the standard method. A saliva or semen extract was mixed with anti-H lectin, anti-A, or anti-B antiserum; if blood-group substance was present in the extract, it would absorb and neutralise the antibody, reducing the titre against indicator cells. A significant titre drop confirmed secretor status and identified the group. Non-secretors produced no titre drop regardless of their ABO group.

Why does non-secretor status matter in forensic casework?

A non-secretor cannot be typed from saliva or semen, because their body fluids carry no ABO substance. This means a stain from a non-secretor will not inhibit anti-A, anti-B, or anti-H regardless of the donor's actual ABO group, potentially leading to misclassification or a failed typing. Knowing that roughly 20% of the population are non-secretors prevents false conclusions about the group status of a stain from a non-secretor donor.

Is secretor testing still done in modern forensic casework?

Classical serological secretor testing has largely been displaced by STR DNA profiling, which is more discriminating and does not depend on body-fluid secretor phenotype. However, secretor status is still genotyped in some research contexts, and understanding it remains important for interpreting historical case results and for understanding why some older stain typings failed or were inconsistent.

Test yourself on Forensic Serology with free, timed mocks.

Practice Forensic Serology questions

Found this useful? Pass it along.

Spotted an error in this page? Report a correction or read our editorial standards.

Population

Approx. secretor %

Approx. non-secretor %

Northern European

78-80%

20-22%

South Asian

75-80%

20-25%

East Asian

76-80%

20-24%

West African

65-75%

25-35%

Amerindian (varies by group)

96-100%

0-4%

Key Takeaways

Secretor status, controlled by the FUT2 gene on chromosome 19, determines whether ABO blood-group antigens appear in soluble form in saliva, semen, and other body fluids; approximately 80% of most populations are secretors.

Non-secretors carry two non-functional FUT2 alleles and produce no H, A, or B substance in secretions; their body-fluid stains cannot be ABO typed serologically regardless of their red-cell group.

The inhibition method, using anti-H lectin, anti-A, and anti-B antisera, was the standard forensic technique for typing saliva and semen stains; significant titre drop confirms the presence of the corresponding blood-group substance.

Combining ABO group and secretor status roughly doubled the discriminating power compared to ABO alone; the 1986 Narborough investigation demonstrated operational-scale secretor screening before DNA profiling superseded these methods.

Secretor typing has largely been displaced by STR DNA profiling but remains important for understanding historical case reports and for interpreting degraded samples where DNA extraction fails.

What does it mean to be a secretor?

Which gene controls secretor status, and how?

How was secretor testing performed on crime-scene samples?

Why does non-secretor status matter in forensic casework?

Is secretor testing still done in modern forensic casework?

Your journey to becoming a forensic professional starts here.

Key Takeaways

Key Takeaways